Latest Insider Transactions at Cytokinetics Inc (CYTK)
This section provides a real-time view of insider transactions for Cytokinetics Inc (CYTK). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of CYTOKINETICS INC to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of CYTOKINETICS INC's insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Mar 06
2024
|
Robert I Blum President & CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
16,725
-4.02%
|
$1,103,850
$66.88 P/Share
|
|
Mar 06
2024
|
Andrew Callos EVP, Chief Commercial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
5,103
-9.8%
|
$336,798
$66.88 P/Share
|
|
Mar 05
2024
|
Fady Ibraham Malik EVP Research & Development |
SELL
Open market or private sale
|
Direct |
32,604
-9.93%
|
$2,184,468
$67.54 P/Share
|
|
Mar 05
2024
|
Fady Ibraham Malik EVP Research & Development |
BUY
Exercise of conversion of derivative security
|
Direct |
28,604
+14.58%
|
$171,624
$6.67 P/Share
|
|
Mar 04
2024
|
Fady Ibraham Malik EVP Research & Development |
SELL
Payment of exercise price or tax liability
|
Direct |
9,630
-6.74%
|
$645,210
$67.68 P/Share
|
|
Mar 04
2024
|
Robert Wong VP, Chief Accounting Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
1,783
-6.32%
|
$119,461
$67.68 P/Share
|
|
Mar 04
2024
|
Robert I Blum President & CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
25,341
-5.74%
|
$1,697,847
$67.68 P/Share
|
|
Mar 04
2024
|
Andrew Callos EVP, Chief Commercial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
2,202
-4.06%
|
$147,534
$67.68 P/Share
|
|
Feb 14
2024
|
John T Henderson Director |
SELL
Open market or private sale
|
Direct |
5,000
-10.5%
|
$380,000
$76.48 P/Share
|
|
Feb 14
2024
|
John T Henderson Director |
BUY
Exercise of conversion of derivative security
|
Direct |
5,000
+9.5%
|
$20,000
$4.44 P/Share
|
|
Feb 13
2024
|
Robert I Blum President & CEO |
SELL
Open market or private sale
|
Direct |
12,500
-2.75%
|
$950,000
$76.85 P/Share
|
|
Feb 13
2024
|
Robert I Blum President & CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
12,500
+2.68%
|
$75,000
$6.67 P/Share
|
|
Feb 06
2024
|
Fady Ibraham Malik EVP Research & Development |
SELL
Open market or private sale
|
Direct |
32,605
-9.51%
|
$2,575,795
$79.29 P/Share
|
|
Feb 06
2024
|
Fady Ibraham Malik EVP Research & Development |
BUY
Exercise of conversion of derivative security
|
Direct |
28,605
+14.01%
|
$171,630
$6.67 P/Share
|
|
Jan 31
2024
|
Robert I Blum President & CEO |
SELL
Open market or private sale
|
Direct |
12,500
-2.75%
|
$987,500
$79.57 P/Share
|
|
Jan 31
2024
|
Robert I Blum President & CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
12,500
+2.68%
|
$75,000
$6.67 P/Share
|
|
Jan 19
2024
|
Robert I Blum President & CEO |
SELL
Open market or private sale
|
Direct |
12,500
-2.75%
|
$1,012,500
$81.42 P/Share
|
|
Jan 19
2024
|
Robert I Blum President & CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
12,500
+2.68%
|
$75,000
$6.67 P/Share
|
|
Jan 12
2024
|
John T Henderson Director |
SELL
Open market or private sale
|
Direct |
5,000
-10.5%
|
$425,000
$85.14 P/Share
|
|
Jan 12
2024
|
John T Henderson Director |
BUY
Exercise of conversion of derivative security
|
Direct |
5,000
+9.5%
|
$20,000
$4.44 P/Share
|
|
Jan 04
2024
|
Fady Ibraham Malik EVP Research & Development |
SELL
Open market or private sale
|
Direct |
15,678
-4.91%
|
$1,348,308
$86.99 P/Share
|
|
Jan 04
2024
|
Fady Ibraham Malik EVP Research & Development |
BUY
Exercise of conversion of derivative security
|
Direct |
11,678
+6.7%
|
$81,746
$7.96 P/Share
|
|
Jan 02
2024
|
Sandford D Smith Director |
BUY
Grant, award, or other acquisition
|
Direct |
148
+0.78%
|
$12,432
$84.12 P/Share
|
|
Jan 02
2024
|
Wendall Wierenga Director |
BUY
Grant, award, or other acquisition
|
Direct |
74
+0.39%
|
$6,216
$84.12 P/Share
|
|
Jan 02
2024
|
Nancy Wysenski Director |
BUY
Grant, award, or other acquisition
|
Direct |
74
+0.43%
|
$6,216
$84.12 P/Share
|
|
Jan 02
2024
|
Robert Arthur Harrington Director |
BUY
Grant, award, or other acquisition
|
Direct |
148
+1.27%
|
$12,432
$84.12 P/Share
|
|
Jan 02
2024
|
John T Henderson Director |
BUY
Grant, award, or other acquisition
|
Direct |
252
+0.59%
|
$21,168
$84.12 P/Share
|
|
Jan 02
2024
|
Edward M. Md Kaye Director |
BUY
Grant, award, or other acquisition
|
Direct |
148
+0.76%
|
$12,432
$84.12 P/Share
|
|
Jan 02
2024
|
Robert I Blum President & CEO |
SELL
Open market or private sale
|
Direct |
12,500
-2.75%
|
$1,062,500
$85.08 P/Share
|
|
Jan 02
2024
|
Robert I Blum President & CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
12,500
+2.68%
|
$75,000
$6.67 P/Share
|
|
Dec 27
2023
|
Wendall Wierenga Director |
SELL
Open market or private sale
|
Direct |
10,000
-21.14%
|
$730,000
$73.6 P/Share
|
|
Dec 27
2023
|
Wendall Wierenga Director |
BUY
Exercise of conversion of derivative security
|
Direct |
10,000
+17.45%
|
$40,000
$4.44 P/Share
|
|
Dec 18
2023
|
John T Henderson Director |
SELL
Open market or private sale
|
Direct |
2,458
-5.48%
|
$88,488
$36.34 P/Share
|
|
Dec 18
2023
|
John T Henderson Director |
BUY
Exercise of conversion of derivative security
|
Direct |
13,020
+22.5%
|
$78,120
$6.72 P/Share
|
|
Dec 18
2023
|
Robert I Blum President & CEO |
SELL
Open market or private sale
|
Direct |
12,500
-2.75%
|
$450,000
$36.95 P/Share
|
|
Dec 18
2023
|
Robert I Blum President & CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
12,500
+2.68%
|
$75,000
$6.67 P/Share
|
|
Nov 30
2023
|
Robert I Blum President & CEO |
SELL
Open market or private sale
|
Direct |
12,500
-2.75%
|
$400,000
$32.99 P/Share
|
|
Nov 30
2023
|
Robert I Blum President & CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
12,500
+2.68%
|
$75,000
$6.67 P/Share
|
|
Nov 15
2023
|
Robert I Blum President & CEO |
SELL
Open market or private sale
|
Direct |
12,500
-2.75%
|
$425,000
$34.57 P/Share
|
|
Nov 15
2023
|
Robert I Blum President & CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
12,500
+2.68%
|
$75,000
$6.67 P/Share
|
|
Nov 09
2023
|
Fady Ibraham Malik EVP Research & Development |
SELL
Open market or private sale
|
Direct |
2,500
-1.63%
|
$87,500
$35.4 P/Share
|
|
Oct 30
2023
|
Robert I Blum President & CEO |
SELL
Open market or private sale
|
Direct |
12,500
-2.75%
|
$400,000
$32.17 P/Share
|
|
Oct 30
2023
|
Robert I Blum President & CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
12,500
+2.68%
|
$75,000
$6.67 P/Share
|
|
Oct 16
2023
|
Robert I Blum President & CEO |
SELL
Open market or private sale
|
Direct |
12,500
-2.75%
|
$412,500
$33.7 P/Share
|
|
Oct 16
2023
|
Robert I Blum President & CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
12,500
+2.68%
|
$75,000
$6.67 P/Share
|
|
Oct 12
2023
|
Fady Ibraham Malik EVP Research & Development |
SELL
Open market or private sale
|
Direct |
2,500
-1.61%
|
$87,500
$35.89 P/Share
|
|
Oct 06
2023
|
Robert I Blum President & CEO |
SELL
Open market or private sale
|
Direct |
12,500
-2.75%
|
$375,000
$30.0 P/Share
|
|
Oct 06
2023
|
Robert I Blum President & CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
12,500
+2.68%
|
$75,000
$6.67 P/Share
|
|
Oct 02
2023
|
Robert Arthur Harrington Director |
BUY
Grant, award, or other acquisition
|
Direct |
448
+3.79%
|
$12,096
$27.88 P/Share
|
|
Oct 02
2023
|
Wendall Wierenga Director |
BUY
Grant, award, or other acquisition
|
Direct |
448
+2.35%
|
$12,096
$27.88 P/Share
|